Learn the story of how Medtronic, one of the world's largest medical equipment and therapies suppliers, generates money and ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Medtronic (NYSE:MDT) is currently navigating a landscape marked by both promising innovations and significant challenges.

Event offered participants essential knowledge on diabetes, focusing on key topics such as patient empowerment, innovative ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Medtronic reported adjusted earnings per share of $1.23 for ... Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. In the fiscal first quarter, Cardiovascular revenues increased 6.9% ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

Shares of Medtronic PLC climbed toward a three-month ... amid strength in its diabetes and cardiovascular business. The company raised the lower ends of its full-year guidance ranges for both ...

Strategics tend to invest in med-tech companies they are looking to acquire or could be acquired. Furthermore, companies like ...